Jeffrey Del Carmen is Chief Commercial Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of CPRX, which is worth approximately $0. The most recent transaction as insider was on Jun 24, 2021, when has been sold 2,930 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Jeffrey Del Carmen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2021
SELL
Payment of exercise price or tax liability
-
2,930 Reduced 29.3%
7,070 Common Stock, par valu...
Jun 24 2021
BUY
Exercise of conversion of derivative security
-
10,000 Added 50.0%
10,000 Common Stock, par valu...
JDC

Jeffrey Del Carmen

Chief Commercial Officer
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX